Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drummond, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drummond, P. D.
Related Collections
Right arrow All Neuro-ophthalmology
Right arrow Vertigo
Right arrow Cardiac
Right arrow Migraine
NEUROLOGY 2005;65:620-622
© 2005 American Academy of Neurology


Brief Communications

Effect of tryptophan depletion on symptoms of motion sickness in migraineurs

Peter D. Drummond, PhD

From the School of Psychology, Murdoch University, Perth, Western Australia.

Address correspondence and reprint requests to Dr. Peter Drummond, School of Psychology, Murdoch University, Perth 6150, Western Australia; e-mail: p.drummond{at}murdoch.edu.au.

Seven hours after 39 migraineurs and 37 controls consumed an amino acid drink that contained or omitted l-tryptophan (thereby reducing brain serotonin synthesis), motion sickness was provoked by the visual illusion of movement. Tryptophan depletion boosted dizziness, nausea, and the illusion of movement in controls to levels that approached those of migraineurs. Thus, reduced brain serotonin activity may promote vestibuloocular disturbances during motion sickness and attacks of migraine.


Supported by grants from the National Health and Medical Research Council of Australia and the U.K. Migraine Trust.

Disclosure: The authors report no conflicts of interest.

Received January 10, 2005. Accepted in final form April 22, 2005.




This article has been cited by other articles:


Home page
NeurologyHome page
Y. Sakai, C. Dobson, M. Diksic, M. Aube, and E. Hamel
Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis
Neurology, February 5, 2008; 70(6): 431 - 439.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. L. Brey
Both migraine and motion sickness may be due to low brain levels of serotonin
Neurology, August 23, 2005; 65(4): E9 - E10.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.